Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.736
+0.016 (2.26%)
Nov 21, 2024, 12:00 PM EST - Market open

Company Description

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus.

It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.

The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.

It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Cosmos Health Inc.
Cosmos Health logo
Country United States
Founded 2009
IPO Date Dec 13, 2013
Industry Medical Distribution
Sector Healthcare
Employees 123
CEO Grigorios Siokas

Contact Details

Address:
141 West Jackson Boulevard, Suite 4236
Chicago, Illinois 60604
United States
Phone 312 536 3102
Website cosmosholdingsinc.com

Stock Details

Ticker Symbol COSM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001474167
CUSIP Number 221413206
ISIN Number US2214133058
Employer ID 27-0611758
SIC Code 5122

Key Executives

Name Position
Grigorios Siokas Chairman and Chief Executive Officer
Georgios Terzis Chief Financial Officer
Nikolaos Bardakis Chief Operating Officer
Demetrios G. Demetriades Secretary and Independent Director

Latest SEC Filings

Date Type Title
Nov 14, 2024 10-Q Quarterly Report
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Nov 12, 2024 8-K Current Report
Oct 29, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 28, 2024 S-1 General form for registration of securities under the Securities Act of 1933
Oct 18, 2024 DEF 14A Other definitive proxy statements
Oct 8, 2024 PRER14A Filing
Oct 1, 2024 PRE 14A Other preliminary proxy statements
Sep 27, 2024 8-K Current Report